Login to Your Account



In the clinic


Wednesday, August 6, 2014
Integra Lifesciences Holdings Corp., of Plainsboro, N.J., completed a multicenter trial evaluating the safety and effectiveness of Integra Dermal Regeneration Template, its bilayer skin replacement system designed to help close wounds and regenerate skin cells for the treatment of diabetic foot ulcers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription